HER2

Clinical trials for HER2 explained in plain language.

Never miss a new study

Get alerted when new HER2 trials appear

Sign up with your email to follow new studies for HER2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New triple therapy shows promise for rare, Hard-to-Treat biliary cancers

Disease control Ongoing

This study tests a combination of chemotherapy (gemcitabine/cisplatin) plus two targeted drugs (trastuzumab and pembrolizumab) as a first treatment for people with HER2-positive bile duct or gallbladder cancer that cannot be removed by surgery. The goal is to see if this triple t…

Matched conditions: HER2

Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Apr 28, 2026 13:02 UTC

HER2

Get alerted when new HER2 trials appear

New triple therapy shows promise for rare, Hard-to-Treat biliary cancers